Novavax Produces MERS-CoV Vaccine Candidate
MERS-CoV is a novel coronavirus first identified in
MERS-CoV was first reported in
About
Forward-Looking Statements
Statements herein relating to the future of
CONTACT:John Herrmann Vice President, General CounselNovavax, Inc. 240-268-2000